Variant report

Variant	nsv1026708
Chromosome Location	chr9:209254-366447
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1907)
CpG islands
(count:488)
Chromatin interactive
region (count:136)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1907 , 50 per page) page: 1 2 3 4 5 6 7 ... 39

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:210220-210873	K562	blood:	n/a	n/a
2	ARID3A	chr9:215966-216247	K562	blood:	n/a	n/a
3	ARID3A	chr9:238911-239096	K562	blood:	n/a	n/a
4	ARID3A	chr9:272095-272522	K562	blood:	n/a	n/a
5	ARID3A	chr9:272758-273406	K562	blood:	n/a	chr9:273064-273079
6	ARID3A	chr9:260270-260544	K562	blood:	n/a	n/a
7	ARID3A	chr9:214214-215154	K562	blood:	n/a	n/a
8	ARID3A	chr9:229136-229466	K562	blood:	n/a	n/a
9	ARID3A	chr9:250210-251866	K562	blood:	n/a	n/a
10	ARID3A	chr9:267916-268404	K562	blood:	n/a	n/a
11	ARID3A	chr9:237608-238477	K562	blood:	n/a	n/a
12	ARID3A	chr9:336046-336405	HepG2	liver:	n/a	n/a
13	ATF1	chr9:270753-271026	K562	blood:	n/a	n/a
14	ATF1	chr9:222266-222777	K562	blood:	n/a	n/a
15	ATF1	chr9:272781-273161	K562	blood:	n/a	n/a
16	ATF1	chr9:312958-313372	K562	blood:	n/a	n/a
17	ATF1	chr9:249153-249485	K562	blood:	n/a	n/a
18	ATF1	chr9:272150-272512	K562	blood:	n/a	n/a
19	ATF1	chr9:211078-211816	K562	blood:	n/a	n/a
20	ATF2	chr9:272677-273240	GM12878	blood:	n/a	n/a
21	ATF2	chr9:297286-297859	GM12878	blood:	n/a	n/a
22	ATF2	chr9:272650-273286	GM12878	blood:	n/a	n/a
23	ATF3	chr9:272081-272576	K562	blood:	n/a	n/a
24	ATF3	chr9:326568-327022	H1-hESC	embryonic stem cell:	n/a	n/a
25	ATF3	chr9:210212-210461	K562	blood:	n/a	n/a
26	BACH1	chr9:214910-215270	H1-hESC	embryonic stem cell:	n/a	n/a
27	BACH1	chr9:214677-214706	H1-hESC	embryonic stem cell:	n/a	n/a
28	BATF	chr9:297420-297885	GM12878	blood:	n/a	chr9:297684-297695 chr9:297685-297695
29	BATF	chr9:297422-297902	GM12878	blood:	n/a	chr9:297684-297695 chr9:297685-297695
30	BATF	chr9:278668-278987	GM12878	blood:	n/a	n/a
31	BCL11A	chr9:331212-331567	H1-hESC	embryonic stem cell:	n/a	n/a
32	BCLAF1	chr9:214465-215559	GM12878	blood:	n/a	n/a
33	BCLAF1	chr9:307023-307293	GM12878	blood:	n/a	n/a
34	BCLAF1	chr9:272658-273387	GM12878	blood:	n/a	chr9:272862-272871
35	BCLAF1	chr9:297343-297922	GM12878	blood:	n/a	chr9:297687-297696 chr9:297688-297697
36	BCLAF1	chr9:297419-297950	GM12878	blood:	n/a	chr9:297687-297696 chr9:297688-297697
37	BCLAF1	chr9:272677-273191	GM12878	blood:	n/a	chr9:272862-272871
38	BHLHE40	chr9:209140-209345	K562	blood:	n/a	n/a
39	BHLHE40	chr9:214569-215152	GM12878	blood:	n/a	n/a
40	BHLHE40	chr9:214650-215428	K562	blood:	n/a	n/a
41	BHLHE40	chr9:214106-214306	K562	blood:	n/a	n/a
42	BHLHE40	chr9:218973-219054	K562	blood:	n/a	n/a
43	BHLHE40	chr9:211108-211404	K562	blood:	n/a	n/a
44	BHLHE40	chr9:215354-215372	GM12878	blood:	n/a	n/a
45	BHLHE40	chr9:270725-270976	GM12878	blood:	n/a	n/a
46	BHLHE40	chr9:259627-260475	K562	blood:	n/a	n/a
47	BHLHE40	chr9:237901-238275	K562	blood:	n/a	chr9:238023-238044
48	BHLHE40	chr9:297517-297717	K562	blood:	n/a	n/a
49	BHLHE40	chr9:214709-215301	HepG2	liver:	n/a	n/a
50	BHLHE40	chr9:272179-272510	K562	blood:	n/a	n/a

(count:488 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:211689-211739	HAEpiC	amniotic membrane:	n/a
2	chr9:273072-273122	ECC-1	luminal epithelium:	n/a
3	chr9:214612-214662	HIPEpiC	eye:	n/a
4	chr9:273072-273122	NT2-D1	testis:	n/a
5	chr9:214690-214740	ovcar-3	ovarian:	n/a
6	chr9:273072-273122	PFSK-1	brain:	n/a
7	chr9:213650-213700	RPTEC	kidney:	n/a
8	chr9:215368-215418	MCF10A-Er-Src	breast:	n/a
9	chr9:215368-215418	HEEpiC	esophagus:	n/a
10	chr9:214690-214740	MCF-7	breast:	n/a
11	chr9:273072-273122	Hepatocyte	liver:	n/a
12	chr9:214690-214740	Hela-S3	cervix:	n/a
13	chr9:214612-214662	AG09319	gingival:	n/a
14	chr9:214690-214740	ProgFib	skin:	n/a
15	chr9:214268-214318	HCPEpiC	choroid plexus:	n/a
16	chr9:214690-214740	NHBE	bronchial:	n/a
17	chr9:213650-213700	BE2_C	brain:	n/a
18	chr9:214690-214740	NB4	blood:	n/a
19	chr9:214690-214740	GM12892	blood:	n/a
20	chr9:211689-211739	GM12891	blood:	n/a
21	chr9:213650-213700	ECC-1	luminal epithelium:	n/a
22	chr9:215561-215611	SK-N-SH_RA	brain:	n/a
23	chr9:215368-215418	HRE	kidney:	n/a
24	chr9:214268-214318	Hela-S3	cervix:	n/a
25	chr9:214268-214318	NHBE	bronchial:	n/a
26	chr9:214268-214318	MCF10A-Er-Src	breast:	n/a
27	chr9:273072-273122	SK-N-SH_RA	brain:	n/a
28	chr9:213650-213700	BJ	skin:	n/a
29	chr9:214690-214740	AG04449	skin:	fetal
30	chr9:214612-214662	NB4	blood:	n/a
31	chr9:215368-215418	Hepatocyte	liver:	n/a
32	chr9:214612-214662	A549	lung:	n/a
33	chr9:215368-215418	HCPEpiC	choroid plexus:	n/a
34	chr9:213650-213700	IMR90	lung:	fetal
35	chr9:211689-211739	H1-hESC	embryonic stem cell:	embryo
36	chr9:215561-215611	ovcar-3	ovarian:	n/a
37	chr9:214612-214662	GM19239	blood:	n/a
38	chr9:214612-214662	HUVEC	blood vessel:	n/a
39	chr9:215368-215418	NHBE	bronchial:	n/a
40	chr9:213650-213700	MCF-7	breast:	n/a
41	chr9:273072-273122	AoSMC	blood vessel:	n/a
42	chr9:211689-211739	GM12892	blood:	n/a
43	chr9:214268-214318	HUVEC	blood vessel:	n/a
44	chr9:211689-211739	HNPCEpiC	eye:	n/a
45	chr9:214268-214318	HCT-116	colon:	n/a
46	chr9:215368-215418	HIPEpiC	eye:	n/a
47	chr9:214268-214318	HMEC	breast:	n/a
48	chr9:273072-273122	HepG2	liver:	n/a
49	chr9:273072-273122	GM12878	blood:	n/a
50	chr9:273072-273122	MCF10A-Er-Src	breast:	n/a

(count:136 , 50 per page) page: 1 2 3

No.	Distal block	Cell Line	Cell type
1	chr9:240408..242135-chr9:247395..249007,2	MCF-7	breast:
2	chr9:318530..320927-chr9:322721..325349,2	K562	blood:
3	chr9:224171..226015-chr9:253370..255238,2	MCF-7	breast:
4	chr9:275975..278627-chr9:279451..282123,3	K562	blood:
5	chr9:214044..216353-chr9:222371..224502,2	MCF-7	breast:
6	chr9:264854..268401-chr9:271602..276392,5	K562	blood:
7	chr9:246962..249799-chr9:250077..252857,2	K562	blood:
8	chr9:275975..278627-chr9:279451..282123,3	K562	blood:
9	chr9:223210..226112-chr9:277917..282090,3	K562	blood:
10	chr9:209849..211411-chr9:213516..215617,2	MCF-7	breast:
11	chr9:224153..226474-chr9:270248..273178,2	K562	blood:
12	chr9:214285..216173-chr9:227690..229444,2	K562	blood:
13	chr9:227507..229537-chr9:238867..240547,2	K562	blood:
14	chr9:324085..328451-chr9:329787..332698,3	K562	blood:
15	chr9:288330..291260-chr9:302503..304653,3	K562	blood:
16	chr9:265556..268525-chr9:268878..270498,2	K562	blood:
17	chr20:61557637..61559255-chr9:214332..216174,2	MCF-7	breast:
18	chr9:207871..210695-chr9:212521..216858,5	MCF-7	breast:
19	chr9:331276..333871-chr9:335644..338943,3	MCF-7	breast:
20	chr9:213656..215329-chr9:262330..263868,2	K562	blood:
21	chr9:218197..221460-chr9:224650..228237,4	K562	blood:
22	chr9:240408..242135-chr9:247395..249007,2	MCF-7	breast:
23	chr9:235818..237375-chr9:247234..248835,2	K562	blood:
24	chr9:211063..213249-chr9:216572..219831,3	K562	blood:
25	chr9:257830..262248-chr9:271354..273884,5	K562	blood:
26	chr9:318530..320927-chr9:322721..325349,2	K562	blood:
27	chr9:288330..291260-chr9:302503..304653,3	K562	blood:
28	chr9:347951..349550-chr9:363997..366575,2	MCF-7	breast:
29	chr9:277861..283096-chr9:291676..296273,5	K562	blood:
30	chr9:210795..213326-chr9:213922..216378,4	MCF-7	breast:
31	chr9:347437..348401-chr9:378296..379161,3	MCF-7	breast:
32	chr9:211790..213319-chr9:241598..244495,2	K562	blood:
33	chr9:211912..213756-chr9:227781..229604,2	K562	blood:
34	chr9:258428..261727-chr9:265742..268870,3	K562	blood:
35	chr9:284961..287002-chr9:306876..309185,2	K562	blood:
36	chr9:268889..271022-chr9:277493..279614,2	K562	blood:
37	chr9:286841..289218-chr9:291668..294143,2	K562	blood:
38	chr9:216842..219174-chr9:220888..224256,4	K562	blood:
39	chr9:223853..225771-chr9:261619..263535,2	K562	blood:
40	chr9:237820..240828-chr9:247584..251042,3	K562	blood:
41	chr9:247322..249745-chr9:277912..279940,2	K562	blood:
42	chr9:213587..215367-chr9:247326..250011,2	MCF-7	breast:
43	chr9:324085..328451-chr9:329787..332698,3	K562	blood:
44	chr9:213589..216422-chr9:270983..274599,7	K562	blood:
45	chr9:239328..240900-chr9:247584..249872,2	K562	blood:
46	chr9:217275..219531-chr9:301975..303827,2	MCF-7	breast:
47	chr9:326951..329483-chr9:330404..332162,2	K562	blood:
48	chr9:213518..215162-chr9:305580..308186,2	K562	blood:
49	chr9:283346..286966-chr9:287946..290894,7	K562	blood:
50	chr9:213452..215018-chr9:305580..307976,2	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-C9orf66-1	chr9:272905-273002	ENSG00000235880.1
2	lnc-C9orf66-1	chr9:267966-268273	ENSG00000235880.1

No data

Variant related genes	Relation type
DOCK8	TF binding region
ENSG00000235880	TF binding region
C9orf66	TF binding region
DOCK8	CpG island
ENSG00000235880	CpG island
C9orf66	CpG island
ENSG00000107099	chromatin interactions
ENSG00000227155	chromatin interactions
ENSG00000235880	chromatin interactions
ENSG00000183784	chromatin interactions
ENSG00000101191	chromatin interactions

Extended variants
information (count: 8594 )
Associated
traits (count: 120 )

Variant overlapped rSNPs/rCNVs (count:8594 , 50 per page) page: 1 2 3 4 5 6 7 ... 172

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs531145521	chr9:209262-209263	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs552468669	chr9:209288-209289	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs571075922	chr9:209290-209291	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs534912839	chr9:209291-209292	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs553519460	chr9:209294-209295	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs568505693	chr9:209323-209324	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs631411	chr9:209325-209326	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
8	rs116090497	chr9:209338-209339	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs114626614	chr9:209354-209355	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs473700	chr9:209359-209360	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
11	rs138545996	chr9:209370-209371	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs113467588	chr9:209372-209373	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs573052891	chr9:209384-209385	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs546264349	chr9:209392-209393	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs540095744	chr9:209400-209401	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs561917091	chr9:209401-209402	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs143800085	chr9:209402-209403	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs1360963	chr9:209403-209404	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs538735922	chr9:209406-209407	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs562211562	chr9:209409-209410	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs62533312	chr9:209411-209412	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
22	rs550920595	chr9:209444-209445	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs571096951	chr9:209477-209478	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs72699402	chr9:209502-209503	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs369343561	chr9:209573-209574	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs568622859	chr9:209583-209584	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs112812740	chr9:209587-209588	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs557510344	chr9:209687-209688	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs78659075	chr9:209729-209730	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs75776778	chr9:209754-209755	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs112289100	chr9:209784-209785	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs558174499	chr9:209852-209853	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs573102350	chr9:209862-209863	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs540501963	chr9:209867-209868	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs555310770	chr9:209876-209877	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs143248810	chr9:209877-209878	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs74521154	chr9:209882-209883	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs543976966	chr9:209899-209900	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs562251094	chr9:209928-209929	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs532852897	chr9:209929-209930	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs544649147	chr9:209947-209948	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs554873364	chr9:209962-209963	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs560069791	chr9:209975-209976	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs574612935	chr9:209986-209987	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs75998544	chr9:209992-209993	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs547287958	chr9:210004-210005	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs533155176	chr9:210014-210015	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs57566376	chr9:210015-210016	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs397971956	chr9:210033-210034	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs367966062	chr9:210034-210035	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:120)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	20164920	CNVD
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
Lynch syndrome	18415027	CNVD
Retinoblastoma	21504564	CNVD
Melanoma	18172304	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	22286061	CNVD
Williams-beuren syndrome	18553513	CNVD
Disorders of sex development	21048976	CNVD
Pilocytic astrocytoma	18622384	CNVD
Pilomyxoid astrocytoma	18622384	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
prenatal diagnosis	20453657	CNVD
Gastric cancer	16715143	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Autism	22495311	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Schizophrenia	20967226	CNVD
Lung cancer	18438408	CNVD
Autism	20531469	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Developmental delay	20808231	CNVD
Obesity	20808231	CNVD
Myelodysplastic syndrome	21251322	CNVD
Primary immunodeficiency	22942019	CNVD
Melanoma	20877625	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	21215367	CNVD
Renal cell carcinoma	21215367	CNVD
Williams Syndrome	20824207	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Pancreatic cancer	17952125	CNVD
T-cell lymphomas	22341440	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21364760	CNVD
Bipolar disorder	19114987	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:2329 , 50 per page) page: 1 2 3 4 5 6 7 ... 47

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:207800-213600	Enhancers	Primary monocytes fromperipheralblood	blood
2	chr9:208600-209800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
3	chr9:208800-209800	Enhancers	Primary hematopoietic stem cells short term culture	blood
4	chr9:208800-209800	Flanking Active TSS	K562	blood
5	chr9:208800-213200	Enhancers	Primary neutrophils fromperipheralblood	blood
6	chr9:209200-209800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
7	chr9:209200-209800	Enhancers	Spleen	Spleen
8	chr9:209800-210400	Enhancers	Monocytes-CD14+_RO01746	blood
9	chr9:209800-211000	Weak transcription	Spleen	Spleen
10	chr9:209800-213400	Enhancers	K562	blood
11	chr9:209800-213600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
12	chr9:209800-214000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
13	chr9:210400-210600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
14	chr9:210600-211000	Enhancers	Monocytes-CD14+_RO01746	blood
15	chr9:210600-211400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
16	chr9:210800-212600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
17	chr9:211000-211400	Enhancers	Pancreas	Pancrea
18	chr9:211000-211400	Enhancers	Spleen	Spleen
19	chr9:211000-214600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
20	chr9:211200-211400	Enhancers	Placenta	Placenta
21	chr9:211200-212200	Enhancers	Adipose Nuclei	Adipose
22	chr9:211400-211600	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
23	chr9:211400-212000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
24	chr9:211400-212200	Enhancers	Breast Myoepithelial Primary Cells	Breast
25	chr9:211400-213600	Weak transcription	Pancreas	Pancrea
26	chr9:211400-214000	Enhancers	Primary B cells from cord blood	blood
27	chr9:211400-214000	Weak transcription	Spleen	Spleen
28	chr9:211600-211800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
29	chr9:211800-212600	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
30	chr9:212000-214400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
31	chr9:212200-214000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
32	chr9:212200-214000	Weak transcription	Adipose Nuclei	Adipose
33	chr9:212400-213000	Enhancers	Primary hematopoietic stem cells	blood
34	chr9:212600-212800	Bivalent/Poised TSS	Fetal Kidney	kidney
35	chr9:212600-212800	Enhancers	Skeletal Muscle Female	skeletal muscle
36	chr9:212600-213000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
37	chr9:212600-213600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
38	chr9:213000-214000	Weak transcription	Primary hematopoietic stem cells	blood
39	chr9:213000-215200	Active TSS	Brain Substantia Nigra	brain
40	chr9:213200-213400	Bivalent/Poised TSS	Fetal Kidney	kidney
41	chr9:213200-214400	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
42	chr9:213400-213800	Flanking Active TSS	K562	blood
43	chr9:213400-214600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
44	chr9:213600-214000	Enhancers	Primary B cells from peripheral blood	blood
45	chr9:213600-214000	Enhancers	Placenta	Placenta
46	chr9:213600-214200	Enhancers	Primary hematopoietic stem cells short term culture	blood
47	chr9:213600-214200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
48	chr9:213600-214400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
49	chr9:213600-214400	Enhancers	Pancreas	Pancrea
50	chr9:213600-214600	Flanking Active TSS	Primary monocytes fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links